Predictors of end- stage renal disease in the urban poor

Journal of Health Care for the Poor and Underserved

Volumn 24, Issue 4, 2013, Pages 1686-1700

  Hall, Yoshio N ^a,e   Choi, Andy I ^b   Xu, Ping ^a   Smith, Nicholas L ^c,e   Boyko, Edward J ^c,d,e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UW ^*  (United States)

^d Division of General Internal Medicine   (United States)

^e VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

Chronic kidney disease; Disparities; End stage renal disease; Public healthcare; Race or ethnicity; Urban poor

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; POVERTY; RETROSPECTIVE STUDY; RISK FACTOR; UNITED STATES; URBAN POPULATION;

ADULT; AGED; COHORT STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; POVERTY; RETROSPECTIVE STUDIES; RISK FACTORS; SAN FRANCISCO; URBAN POPULATION;

EID: 84887100859     PISSN: 10492089     EISSN: 15486869     Source Type: Journal    
DOI: 10.1353/hpu.2013.0189     Document Type: Article

References (41)

1. Karter AJ, Ferrara A, Liu JY, et al. Ethnic disparities in diabetic complications in an insured population. JAMA. 2002 May 15;287(19):2519-2527
2. Klag MJ, Whelton PK, Randall BL, et al. End- stage renal disease in African- American and white men. 16-year MRFIT findings. JAMA. 1997 Apr 23-30;277(16):1293-1298
3. Hsu CY, Lin F, VittinghoffE, et al. Racial differences in the progression from chronic renal insufficiency to end- stage renal disease in the United States. J Am Soc Nephrol. 2003 Nov;14(11):2902-7
4. Hall YN, Hsu CY, Iribarren C, et al. The conundrum of increased burden of end- stage renal disease in Asians. Kidney Int. 2005 Nov;68(5):2310-6
5. Collins AJ, Foley RN, Herzog C, et al. U.S. Renal Data System 2010 annual data report: atlas of chronic kidney disease and end- stage renal disease in the United States. Am J Kidney Diseases. 2011 Jan;57(1 Suppl 1):e1-e526
6. Gaskin DJ, Hadley J. Population characteristics of markets of safety- net and nonsafety- net hospitals. J Urban Health. 1999 Sep;76(3):351-70
7. Regenstein M, Sickler D. Race, ethnicity, and language of patients: hospital practices regarding collection of information to adress disparties in healThcare. Washington, DC: National Public HealThand Hospital Institute, 2006. Available at: http://www.naph.org/Main-Menu-Category/Our-Work/Health-Care-Disparities/raceethnicityandlanguageofpatients.aspx.
8. Kern EF, Maney M, Miller DR, et al. Failure of ICD-9-CM codes to identify patients wiThcomorbid chronic kidney disease in diabetes. HealThServ Res. 2006 Apr;41(2): 564-80
9. Powe NR, Plantinga L, Saran R. Public healThsurveillance of CKD: principles, steps, and challenges. Am J Kidney Dis. 2009 Mar;53(3 Suppl 3):S37-45
10. Hall YN, Choi AI, Chertow GM, et al. Chronic kidney disease in the urban poor. Clin J Am Soc Nephrol. 2010 May;5(5):828-35. Epub 2010 Mar 3
11. Iseki K, Ikemiya Y, Iseki C, et al. Proteinuria and the risk of developing end- stage renal disease. Kidney Int. 2003 Apr;63(4):1468-74
12. Hemmelgarn BR, Manns BJ, Lloyd A, et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA. 2010 Feb 3;303(5):423-9
13. Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV- infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005 Jun 1;40(11):1559-85. Epub 2005 Apr 22
14. Choi AI, Rodriguez RA, Bacchetti P, et al. The impact of HIV on chronic kidney disease outcomes. Kidney Int. 2007 Dec;72(11):1380-7. Epub 2007 Sep 5
15. Schillinger D, Bibbins- Domingo K, Vranizan K, et al. Effects of primary care coordination on public hospital patients. J Gen Intern Med. 2000 May;15(5):329-36
16. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003 Jul 15;139(2):137-47
17. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999 Mar 16;130(6):461-70
18. Lamb EJ, MacKenzie F, Stevens PE. How should proteinuria be detected and measured? Ann Clin Biochem. 2009 May;46(Pt 3):205-17
19. Cox DR, Oakes D. Analysis of survival data. Boca Raton, FL: Chapman & Hall/ CRC Press, 1984
20. Little RJA, Rubin DB. Statistical analysis wiThmissing data. New York, NY: John Wiley & Sons, 1987
21. Zaman OS, Cummings LC, Spieler SS. America's public hospitals and healThsystems, 2008: results of the annual National Association of Public Hospitals and HealThSystems (NAPH) Hospital Characteristics Survey. Washington, DC: National Association of Public Hospitals and HealThSystems, 2010. Available at: http://www.naph.org/Main-Menu-Category/Publications/Safety-Net-Financing/Characteristics-2008.aspx.
22. Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011 Apr 20;305(15):1553-9. Epub 2011 Apr 11
23. Peralta CA, Shlipak MG, Fan D, et al. Risks for end- stage renal disease, cardiovascular events, and deaThin Hispanic versus non- Hispanic white adults with chronic kidney disease. J Am Soc Nephrol. 2006 Oct;17(10):2892-9. Epub 2006 Sep 7
24. O'Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007 Oct;18(10):2758-65. Epub 2007 Sep 12
25. Choi AI, Rodriguez RA, Bacchetti P, et al. Racial differences in end- stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol. 2007 Nov;18(11):2968-74. Epub 2007 Oct 17
26. Fernandez A, Schillinger D, Warton EM, et al. Language barriers, physician- patient language concordance, and glycemic control among insured Latinos wiThdiabetes: the Diabetes Study of Northern California (DISTANCE). J Gen Intern Med. 2011 Feb;26(2):170-6
27. Kim G, Worley CB, Allen RS, et al. Vulnerability of older Latino and Asian immigrants wiThlimited English proficiency. J Amer Geriatr Soc. 2011 Jul;59(7):1246-52.Epub 2011 Jun 30
28. Rhee MS, Schmid CH, Stevens LA, et al. Risk factors for proteinuria in HIV- infected and -uninfected Hispanic drug users. Am J Kidney Dis. 2008 Oct;52(4):683-90. Epub 2008 Jun 24
29. Rao TK, Nicastri AD, Friedman EA. Natural history of heroin- associated nephropathy. N Engl J Med. 1974 Jan 3;290(1):19-23
30. Eknoyan G, Gyorkey F, Dichoso C, et al. Renal involvement in drug abuse. Arch Intern Med. 1973 Dec;132(6):801-6
31. Bakir AA, Dunea G. Drugs of abuse and renal disease. Curr Opin Nephrol Hypertens. 1996 Mar;5(2):122-6
32. Hsu CY, Iribarren C, McCulloch CE, et al. Risk factors for end- stage renal disease: 25-year follow-up. Arch Intern Med. 2009 Feb 23;169(4):342-50
33. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004 Sep 23;351(13):1296-305
34. Klag MJ, Whelton PK, Randall BL, et al. End- stage renal disease in African- American and white men. 16-year MRFIT findings. JAMA. 1997 Apr 23-30;277(16):1293-8
35. Hall YN, Hsu CY, Iribarren C, et al. The conundrum of increased burden of end- stage renal disease in Asians. Kidney Int. 2005 Nov;68(5):2310-6
36. Genovese G, Friedman DJ, Ross MD, et al. Association of trypanolytic ApoL1 variants wiThkidney disease in African Americans. Science. 2010 Aug 13;329(5993):841-5. Epub 2010 Jul 15
37. Pollak MR, Genovese G, Friedman DJ. APOL1 and kidney disease. Curr Opin Nephrol Hypertens. 2012 Mar;21(2):179-82
38. Jackson JS, Knight KM, Rafferty JA. Race and unhealthy behaviors: chronic stress, the HPA axis, and physical and mental healThdisparities over the life course. Am J Public Health. 2010 May;100(5):933-9. Epub 2009 Oct 21
39. Saha S, Komaromy M, Koepsell TD, et al. Patient- physician racial concordance and the perceived quality and use of healThcare. Arch Intern Med. 1999 May 10;159(9):997-1004
40. Ko RJ. Adulterants in Asian patent medicines. N Engl J Med. 1998 Sep 17;339(12):847
41. Tofovic SP, Dubey R, Salah EM, et al. 2-Hydroxyestradiol attenuates renal disease in chronic puromycin aminonucleoside nephropathy. J Am Soc Nephrol. 2002 Nov;13(11):2737-47.